Navigation Links
Lupus Community Rallies Behind Fiancee With Lupus in 'Race to the Altar'
Date:5/23/2008

WASHINGTON, May 23 /PRNewswire-USNewswire/ -- People living with the autoimmune disease lupus, and their families and friends, are rallying behind a couple competing in the NBC TODAY Show's annual "Race to the Altar." Annie and Tom of Chicago, Illinois are one of four couples who seek to be married in June live on the TODAY Show.

Annie was diagnosed with lupus at age 17. Because lupus is a lifelong and sometimes disabling chronic disease, Annie feared that she would never find true love or be accepted for who she really is as a person. However, it was Annie's inner strength and drive that grew from her struggles with lupus that her future husband, Tom, admires about her most.

The Lupus Foundation of America (LFA) is supporting Annie and Tom's efforts to be selected as this year's winning couple. Like Annie, young women with lupus often have to battle not only the physical burdens of the disease, but also the emotional toll that a disease like lupus can extract.

The LFA urges everyone touched by lupus to help Annie and Tom have a memorable wedding broadcast live to millions of viewers from the Plaza outside the TODAY show studios. Vote for Annie and Tom by going online to today.msnbc.com or by texting the number 4 to 46833 before noon Eastern Time on Monday, May 26.

About Lupus

Lupus results from an unbalanced immune system that can become destructive to any tissue or organ in the body. Lupus is unpredictable and potentially fatal, yet no satisfactory treatment or cure exists. At least 1.5 million Americans are living with a form of lupus, the consequences of which can include heart attacks, strokes, seizures and organ failure. For more information, visit the LFA Website at lupus.org.

About the LFA

The LFA is the foremost national nonprofit voluntary health organization dedicated to finding the causes of and cure for lupus and providing support, services, and hope to all people affected by lupus. The LFA and its
'/>"/>

SOURCE Lupus Foundation of America
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine news :

1. Preclinical study suggests organ-transplant drug may aid in lupus fight
2. Genes Boost Risk for Rheumatoid Arthritis, Lupus
3. The Will and Jada Smith Family Foundation and Maybelline Join Forces With the Lupus Foundation of America for a Star-studded Gala to Raise Awareness for Lupus
4. Better Lupus Treatments on the Horizon
5. Stars Shine on Butterflies Over Hollywood for Lupus Foundation of America
6. Clinical Trials for Lupus Underway After Decades of Drought
7. October is Lupus Awareness Month
8. New Round of Lupus Research Institute Awards Brings Promise of More Breakthroughs
9. Photo: New York Goes Orange for Pumpkin Festival and Lupus Awareness Month
10. Mayo Clinic shows therapy effective for reducing lupus flares
11. Research suggests targeted treatment strategies for lupus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2009)... Today the Centers for Disease Control and Prevention (CDC) ... the week was designed to highlight the importance of ... of taking additional steps to keep you and your ... of December, January and beyond. ,, "It,s easy to ... topic of both seasonal and swine flu," said Dr. ...
(Date:12/6/2009)... The University HealthSystem Consortium (UHC) recognized ... achievements in UHC,s Supply Chain Optimization Program. The ... modeling best practices in supply chain program participation. ... The winners were determined using 2008 data and ... participation and use of UHC resources. ,, Characteristics ...
(Date:12/6/2009)... targeting growth factor, researchers say , , SUNDAY, Dec. ... cells from the main tumor to other parts of ... as TGFb, which may prove a promising target for ... say. , Previous studies have shown that TGFb (transforming ... In this new study, a team from Cancer Research ...
(Date:12/6/2009)... Blood clotting, or coagulation, is an important process ... is injured. Sometimes, however, clots form on the ... do not dissolve naturally, a potentially life-threatening situation ... Annual Meeting of the American Society of Hematology ... aspirin and heparin with the hope of preventing ...
(Date:12/5/2009)... in a phase 1/2 clinical trial that it ... patients newly diagnosed with multiple myeloma, a cancer of ... Dana-Farber Cancer Institute. , Partial responses or better were ... the drug combination in the multi-center study, with 74 ... the phase 2 population, reports Paul G. Richardson, MD, ...
Breaking Medicine News(10 mins):Health News:As CDC Kicks Off National Influenza Vaccination Week, It Is More Important than Ever to Take Preventative Measures Against Cold & Flu 2Health News:As CDC Kicks Off National Influenza Vaccination Week, It Is More Important than Ever to Take Preventative Measures Against Cold & Flu 3Health News:Recognized Top Performers in UHC Supply Chain 2Health News:Breast Cancer's Spread Now Better Understood 2Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 2Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 3Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 4Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 5Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 6Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 7Health News:Multiple myeloma patients experience high response rate with new 3-drug combination 2
... babies develop a fever high enough or abrupt enough ... to the emergency room, where their workup frequently includes ... meningitis. Now, in the largest study to date, researchers ... is probably not necessary in well-appearing children who have ...
... HAMILTON, Bermuda, Jan. 6 Warner Chilcott Limited (Nasdaq: ... signed an agreement with Dong-A PharmTech Co. Ltd., based ... product, a phosphodiesterase type 5 (PDE5) inhibitor for the ... Dong-A has successfully completed Phase 2 studies of ...
... Study found both physical function and quality of life improved ... of its kind finds that deep brain stimulation improves both ... patients with Parkinson,s disease. , Deep brain stimulation (DBS) performed ... some risks, including one death, according to a study in ...
... Gentiva Health Services, Inc. (Nasdaq: GTIV ), ... that it plans to present from 8:30 a.m. to 9:00 ... J.P. Morgan Healthcare Conference in San Francisco. , The presentation ... web cast, which may be accessed by visiting http://investors.gentiva.com/events.cfm ...
... , ... Tampa, Fla. (Vocus) January 6, 2009 -- Whether you commit to your ... pets this year by bringing them in for regular check ups. Regular ... lead to a loved one,s life saved and less costly medical bills for ...
... the Centers for Disease Control and Prevention have produced the ... in sheep and human illness. , Dr. Edward Breitschwerdt, professor ... and NC State colleague Dr. Ricardo Maggi isolated the bacterium ... B. melophagi is such a newly discovered member ...
Other Medicine News:Health News:Most babies with uncomplicated febrile seizures can avoid spinal tap 2Health News:Most babies with uncomplicated febrile seizures can avoid spinal tap 3Health News:Warner Chilcott and Dong-A Sign U.S. License Agreement For Erectile Dysfunction Treatment 2Health News:Warner Chilcott and Dong-A Sign U.S. License Agreement For Erectile Dysfunction Treatment 3Health News:Deep Brain Stimulation Helps Those With Advanced Parkinson's 2Health News:Deep Brain Stimulation Helps Those With Advanced Parkinson's 3Health News:Gentiva(R) Health Services to Present January 13 at J.P. Morgan Healthcare Conference in San Francisco 2Health News:Gentiva(R) Health Services to Present January 13 at J.P. Morgan Healthcare Conference in San Francisco 3Health News:Early Detection Saves Pets 2Health News:Early Detection Saves Pets 3Health News:NC State researchers find new bartonella species that infects humans 2
(Date:12/4/2009)... Dec. 4 Dynatronics Corporation (Nasdaq: DYNT ) ... provide therapy equipment and rehab supplies to Benchmark Physical ... ,, "We are pleased to be named the ... Beardall, executive vice president of sales and marketing at ...
(Date:12/4/2009)... WASHINGTON, Dec. 4 Chemistry World recently highlighted ... Research and Manufacturers of America ( PhRMA ) that ... and related conditions. ,, The report found that ... antivirals. These drugs are either in human clinical trials or ...
(Date:12/4/2009)... Inc. (NYSE Amex: PIP ), a biodefense ... threats, announced today that the Company is presenting ... Valortim® in an inhalation anthrax model in the ... are being presented during an oral session at ...
Breaking Medicine Technology:U.S. Pharmaceutical Companies Developing 97 New Drugs and Vaccines to Fight HIV/AIDS 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 3PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 4PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 6Influenza monitoring by the US military 50914 1Influenza monitoring by the US military 50914 2Food crisis and global health workshop July 14 16 50910 1When it comes to brain damage blankets take the place of drugs 9135 1
... phase II/III study demonstrates C1-INH is effective treatment for ... ... 6 CSL Behring has submitted,a biologics license application (BLA) to ... C1-esterase,inhibitor concentrate in the United States for the treatment of hereditary,angioedema ...
... demonstrates BSGI is ... both patient and cost effective., NEWPORT NEWS, ... Bertrand, Director of Breast Imaging at Solis Bertrand Breast,Center in ... (BSGI) as an adjunctive procedure in breast,diagnostics; specifically demonstrating BSGI ...
Other Medicine Technology:CSL Behring Submits BLA Requesting Approval of C1-Esterase Inhibitor for the Treatment of Hereditary Angioedema 2Bertrand Study Finds Significant Value in Breast-Specific Gamma Imaging (BSGI) as an Adjunctive Procedure in Breast Diagnostics 2Bertrand Study Finds Significant Value in Breast-Specific Gamma Imaging (BSGI) as an Adjunctive Procedure in Breast Diagnostics 3
... of Alcon Acrylic, Chiron/Iolab LI-41 and Pharmacia & ... taller and thinner, maximizing the surface area around ... during loading and insertion, and makes it easy ... lens optic. The special direct-acting jaws release the ...
... / Ker Accuref K 9001 ... LCD color monitor. 3 step ... 2.3 mm Minimum pupil diameter ... adjuster. Auto start function. Kerato-Peripheral ...
... offers accuracy, speed, ease of use, ... is an Auto Refractor/Keratometer with both ... elevation, automatic alignment, focusing, printing, high-speed ... other features that have made the ...
Neomycin and Polymyxin B Sulfates and Hydrocortisone ophthalmic suspension is a sterile antimicrobial and anti-inflammatory suspension for ophthalmic use....
Medicine Products: